Article

Exome sequencing identifies somatic point mutations associated with acquired endocrine resistance in breast cancer cell lines

2012-01-01

Abstract excerpt

No abstract is available from the source.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 68a31244-530e-59ec-9885-7d8bfd7be832
DOI: 10.1186/1753-6561-6-s6-p35
PMCID: PMC3467567

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Exome sequencing identifies somatic point mutations associated with acquired endocrine resistance in breast cancer cell linesDOI 10.1186/1753-6561-6-s6-p35Read

Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance.Semantic proximity Read

Estrogen receptor mutations and their role in breast cancer progression.Semantic proximity Read

Activating ESR1 mutations in hormone-resistant metastatic breast cancer.Semantic proximity Read

BRCA2 Reversion Mutation Associated With Acquired Resistance to Olaparib in Estrogen Receptor-positive Breast Cancer Detected by Genomic Profiling of Tissue and Liquid BiopsySemantic proximity Read

Genomic mechanisms of resistance to tyrosine kinase inhibitors in HER2 amplified breast cancerSemantic proximity Read

Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts.Semantic proximity Read

ESR1 mutations and therapeutic resistance in metastatic breast cancer: progress and remaining challenges.Semantic proximity Read

Integrated DNA and RNA Sequencing Reveals Drivers of Endocrine Resistance in Estrogen Receptor–Positive Breast CancerSemantic proximity Read

Genomic landscape of extraordinary responses in metastatic breast cancer.Semantic proximity Read

Genomic hallmarks of endocrine therapy resistance in ER/PR+HER2- breast tumoursSemantic proximity Read

Endocrine therapy resistance: new insights.Semantic proximity Read

Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer.Semantic proximity Read